Adicet Bio ACET
NASDAQ ACET
$4.28 -0.21 (-4.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Preferred Stock Liabilities (2017)

Updated

Adicet Bio (ACET) reported Preferred Stock Liabilities of $81.62 million for Q4 2017.

Analysis

Adicet Bio (ACET) Preferred Stock Liabilities (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Adicet Bio 45.67 Mn -471.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 81.62 Mn
API Access

Adicet Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ACET&period=max&api_key=YOUR_API_KEY